A prescription platform vaccine has three essential elements. A vector, a gene of interest and a USDA-CVB licensed manufacturing process. The vector is the backbone of the vaccine and is the same for every vaccine produced under the prescription platform license. The result is a consistent, reliable, and safe vaccine. The advantage this creates is that we can formulate a vaccine that has the most up to date viral strains and we don't have to isolate a virus to make a vaccine.

Medgene has been working closely with producers since our founding in 2011. We have developed vaccines for a variety of emerging and rapidly changing diseases affecting producers. 

Rabbit Hemorrhagic Disease is a highly contagious, fatal disease in rabbits and is currently classified as a reportable, foreign animal disease in the United States. Animal health officials detected rabbit hemorrhagic disease virus serotype 2 (RHDV2) for the third time in the United States in February 2020. It has since been spreading across the country.

Epizootic Hemorrhagic Disease (EHD), which is spread by a biting insect called a midge, is a viral disease that occurs naturally, can infect white-tailed deer and has a high mortality rate.